EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Interplay of Oxidative Stress, Gut Microbiota, and Nicotine in Metabolic-Associated Steatotic Liver Disease (MASLD)

Irene Mignini iD, Linda Galasso, Giulia Piccirilli, Valentin Calvez, Fabrizio Termite iD, Giorgio Esposto iD, Raffaele Borriello iD, Luca Miele iD, Maria Elena Ainora iD, Antonio Gasbarrini iD, Maria Assunta Zocco iD

Antioxidants · 14.12.2024 · 13 (12) · 1532

DOI: 10.3390/antiox13121532 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 14.12.2024. Verfasst von Irene Mignini und 10 weiteren Autor:innen. Beteiligte Einrichtung: CEMAD Digestive Diseases Center, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 0…. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxidative stress has been described as one of the main drivers of intracellular damage and metabolic disorders leading to metabolic syndrome, a major health problem worldwide. In particular, free radicals alter lipid metabolism and promote lipid accumulation in the liver, existing in the hepatic facet of metabolic syndrome, the metabolic dysfunction-associated steatotic liver disease (MASLD). Recent literature has highlighted how nicotine, especially if associated with a high-fat diet, exerts a negative effect on the induction and progression of MASLD by upregulating inflammation and increasing oxidative stress, abdominal fat lipolysis, and hepatic lipogenesis. Moreover, considerable evidence shows the central role of intestinal dysbiosis in the pathogenesis of MASLD and the impact of nicotine-induced oxidative stress on the gut microbiome. This results in an intricate network in which oxidative stress stands at the intersection point between gut microbiome, nicotine, and MASLD. The aim of this review is to delve into the molecular mechanisms linking tobacco smoking and MASLD, focusing on nicotine-induced microbiota modifications and their impact on MASLD development.

Schlagwörter

Stichwörter der Autor:innen

cigarette smokinggut microbiotagut–liver axismetabolic-associated steatotic livernicotineoxidative stress

Autor:innen und Institutionen

  • CEMAD Digestive Diseases Center, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy.

ORCID-Profile: Irene Mignini, Fabrizio Termite, Giorgio Esposto, Raffaele Borriello, Luca Miele, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco

Zitieren

APA

Mignini, I., Galasso, L., Piccirilli, G., Calvez, V., Termite, F., Esposto, G., Borriello, R., Miele, L., Ainora, M. E., Gasbarrini, A., & Zocco, M. A. (2024). Interplay of Oxidative Stress, Gut Microbiota, and Nicotine in Metabolic-Associated Steatotic Liver Disease (MASLD). Antioxidants, 13(12), 1532. https://doi.org/10.3390/antiox13121532

Vancouver

Mignini I, Galasso L, Piccirilli G, Calvez V, Termite F, Esposto G, et al. Interplay of Oxidative Stress, Gut Microbiota, and Nicotine in Metabolic-Associated Steatotic Liver Disease (MASLD). Antioxidants. 2024;13(12):1532. doi:10.3390/antiox13121532

BibTeX
@article{Mignini2024,
  author = {Mignini, Irene and Galasso, Linda and Piccirilli, Giulia and Calvez, Valentin and Termite, Fabrizio and Esposto, Giorgio and Borriello, Raffaele and Miele, Luca and Ainora, Maria Elena and Gasbarrini, Antonio and Zocco, Maria Assunta},
  title = {Interplay of Oxidative Stress, Gut Microbiota, and Nicotine in Metabolic-Associated Steatotic Liver Disease (MASLD)},
  journal = {Antioxidants},
  year = {2024},
  volume = {13},
  number = {12},
  pages = {1532},
  doi = {10.3390/antiox13121532}
}
Kostenlos starten →